Stoke Therapeutics, Inc.
STOK
$33.61
$0.631.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.09% | 8.61% | 527.99% | 61.12% | -7.69% |
| Total Depreciation and Amortization | -18.15% | -18.61% | -15.28% | -15.71% | -15.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.18% | 13.47% | 15.53% | 5.78% | 7.49% |
| Change in Net Operating Assets | 65.49% | -36,976.67% | 347.56% | -2,205.83% | -823.93% |
| Cash from Operations | -40.49% | -45.46% | 636.62% | -12.32% | -25.22% |
| Capital Expenditure | -28.16% | -234.78% | -1,166.67% | 81.66% | 73.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.86% | -68.11% | 37.84% | -94.26% | -299.34% |
| Cash from Investing | 130.31% | -68.19% | 36.48% | -94.46% | -305.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.76% | -99.54% | -19.98% | -92.26% | 1,351.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.76% | -99.54% | -19.98% | -92.26% | 1,351.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.23% | -1,263.78% | 1,241.69% | -1,588.46% | -1,986.41% |